Growth triggers, valuations drive Britannia stock; Covid impact subdued

Market share improvement, uptick in margins to sustain gains over the medium term

britannia
While volumes and revenues for 9MFY21 grew 11-14 per cent, analysts expect sales growth in the March quarter to come in at 9 per cent
Ram Prasad Sahu
2 min read Last Updated : Apr 08 2021 | 1:54 AM IST
Britannia Industries has gained 10 per cent over the last couple of weeks, driven by a rebound in demand, expectations of steady performance in the March quarter, lower impact of the second wave of Covid infections, and attractive valuations.  

Analysts, led by Amnish Aggarwal of Prabhudas Lilladher, highlighted in a recent report that demand in the biscuit segment had returned to pre-Covid levels. While there has been a shift in favour of large packs in metros and tier-I cities, out-of-home consumption has driven sales of affordable packs. 

Though the second wave of infections and the resulting lockdowns/restrictions will curb the out-of-home market, analysts at Motilal Oswal Research believe the company will be less impacted by this, thanks to gains expected from in-home consumption and lower trade discounts. The near-term trigger will be the Q4 results and outlook.

While volumes and revenues for 9MFY21 grew 11-14 per cent, analysts expect sales growth in the March quarter to come in at 9 per cent. This will be led by volumes as there has not been any significant increase in product prices. Volume growth, moderate input costs, and higher efficiencies are expected to help improve operating profit margins by over 200 bps year-on-year (YoY) to 18 per cent. 

Though crude palm oil and packaging material costs are up sharply YoY, it has been partly offset by the deflationary trend in wheat, sugar, and milk. 

In the near-to-medium term, the key revenue growth drivers will be product innovation, recovery in urban markets, strong growth in adjacencies (cake, rusk, dairy products), and the potential for market share gains in the Hindi-speaking belt, according to Sharekhan.  

Despite the growth outlook, the stock has underperformed the benchmarks and its peers over the last year. 

At the current price, the stock is trading at 41x its FY23 earnings estimates, which is at a discount to its 3-year and 5-year average valuations. 

Any weakness in share prices could be a buying opportunity from a long-term perspective.


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusBrittaniaFMCGs

Next Story